FridayNov 03, 2023 11:02 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Featured in BTV Release Discussing Iska Iska MRE Results

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, has released the results from its recent Mineral Resource Estimate (“MRE”) for the Iska Iska deposit in southern Bolivia. Eloro Resources CEO and chair Thomas Larsen is featured in a recent video release from BTV talking about the results. Highlights of the report indicate 298 million ounces silver, 4.09 million tones zinc, 1.74 million tonnes lead and 130,000 tonnes tin at the deposit. BTV is a TV production and digital marketing agency that helps companies strengthen their brand awareness and reach a national retail and…

Continue Reading

FridayNov 03, 2023 9:45 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Interviewed for New to the Street Segment Regarding Fines for Bank Privacy Violations

U.S. regulatory agencies are fining banks and other financial institutions millions of dollars for privacy violations Fines range up to $50 million per occurrence, but Sekur’s services offer an immediate and cost-effective solution to avoid fines Sekur offers Chat-by-Invite, SekurMessenger, and SekurMail as a fully encrypted communications platform that financial institutions can utilize to safeguard their data and comply with U.S. regulations Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications, was recently featured on the New to the Street segment “Sekur Privacy & Sekur Security…

Continue Reading

FridayNov 03, 2023 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) PRV Sale Prospects Strengthened by Recent Industry Developments

PaxMedica, with the help of financial services firm Bourne Partners, is actively exploring presale of its Priority Review Voucher (“PRV”), highly valuable in the pharmaceutical marketplace once it gets formal approval from the FDA The move is the next step in PaxMedica's ongoing commitment to advancing innovative healthcare solutions for autism patients worldwide Similar successful endeavors in the pharmaceutical landscape have demonstrated lucrative potential PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has set its sights on an exciting potential opportunity. With the engagement of Bourne Partners, a prominent financial services firm specializing in…

Continue Reading

ThursdayNov 02, 2023 2:33 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Featured in Swiss Made Cybersecurity Podcast

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a cybersecurity and internet privacy provider of Swiss hosted solutions for secure and private communications, was featured in a recent Swiss Made Cybersecurity podcast. Alain Ghiai, the founder and CEO of Sekur, joined the program’s host, Paul John Spaulding, to discuss business email compromise (“BEC”) scams and how to defend against them. “BEC, or business email compromise, essentially is the act of a hacker snooping around your emails, especially business emails because in the business world you exchange a lot of valuable… and proprietary information… So it’s the act of somebody…

Continue Reading

ThursdayNov 02, 2023 1:38 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Provides Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared an open letter to shareholders from CEO David Michery, providing updates on various matters and company initiatives. In the letter, Michery highlights several recent company accomplishments, including its commencement of Class 1 EV cargo vans on Nov. 1, 2023. “Over the past few months, the company has reached critical milestones towards accomplishing our ultimate goal to be a leader in the EV industry,” Michery stated in the letter. “We remain steadfastly dedicated to our employees, stakeholders and customers during this journey and thank you for your continued support…

Continue Reading

ThursdayNov 02, 2023 12:21 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured in Bell2Bell Podcast

Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Diamond Lake’s CEO Brian J. Esposito joined the program to discuss DLMI’s business model, operating markets and leadership team. “The best way I can describe what we’re building here at DLMI is an old-school General Electric/Berkshire Hathaway approach where we’re going to have an umbrella holding company of all of these wonderful subsidiaries across…

Continue Reading

ThursdayNov 02, 2023 11:44 am

QualityStocksNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD), Bourne Partners to Collaborate in Evaluating Future Monetization of Potential PRV

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, is working with leading financial services firm Bourne Partners. Bourne Partners specializes in the pharma, pharma services and consumer health spaces. According to the announcement, the collaboration is an important step in PaxMedica's strategy to explore potential monetization of a Priority Review Voucher prior to filing the NDA for PAX-101 for the treatment of African Sleeping Sickness. Although PaxMedica has not yet been granted a PRV and there is no guarantee that one will be awarded, the company believes  PAX-101 qualifies for the PRV program because African Sleeping…

Continue Reading

ThursdayNov 02, 2023 10:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results for INM-755 at 12th Annual WCI

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be presenting an oral presentation at the 12th World Congress on Itch (“WCI”); the event is scheduled for Nov. 5–7, 2023, in Miami. According to the announcement, the oral presentation is based on an abstract describing the phase 2 clinical study of investigational drug INM-755 cannabinol cream for the treatment of symptoms in patients with rare genetic skin disease called epidermolysis bullosa ("EB"). InMed Pharmaceuticals senior vice president of Clinical and Regulatory Affairs Alexandra Mancini will be presenting. The…

Continue Reading

ThursdayNov 02, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) and Satispay Build Quantum Hybrid Application Designed to Optimize Customer Rewards Initiatives

Application showed an improvement of 50% in customer rewards program effectiveness for the same amount of budget Italian fintech company Satispay anticipates that its internal teams will use the application weekly when the company transitions it into production D-Wave’s suite of services is backed by two decades of quantum technology development and over ten years of customer feedback, which have been incorporated to create the industry’s first quantum computer designed for commercial business applications D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced that it…

Continue Reading

ThursdayNov 02, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Webcast at Lytham Fall Investor Conference Highlights Company’s Innovation and Growth with New Solution for Rodent Control

Rat populations have created concerns for centuries because of their potential to be a vector for diseases, their destruction of infrastructure, and their consumption or spoilage of stored food supplies Arizona-based SenesTech Inc. is now introducing its new Evolve(TM) Soft Bait as a companion to its patented ContraPest(R) liquid product as means of shifting rodent control methods from lethal poisons to preventative birth control formulations, with Evolve(TM) Soft Bait representing a big step into a major new market The company recently discussed its operation and plans for the near future during a webcast presentation as part of Lytham Partners’ Fall…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered